DK210788A - Diagnostisk bestemmelse af inhibitor af vaevs-type-plasminogen-aktivatorer og gen kodende for inhibitoren - Google Patents

Diagnostisk bestemmelse af inhibitor af vaevs-type-plasminogen-aktivatorer og gen kodende for inhibitoren

Info

Publication number
DK210788A
DK210788A DK210788A DK210788A DK210788A DK 210788 A DK210788 A DK 210788A DK 210788 A DK210788 A DK 210788A DK 210788 A DK210788 A DK 210788A DK 210788 A DK210788 A DK 210788A
Authority
DK
Denmark
Prior art keywords
inhibitor
gene coding
table type
type plasminogen
plasminogen activators
Prior art date
Application number
DK210788A
Other languages
English (en)
Other versions
DK210788D0 (da
DK175519B1 (da
Inventor
David J Loskutoff
Tor Ny
Michael Sawdey
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25408764&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK210788(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK210788D0 publication Critical patent/DK210788D0/da
Publication of DK210788A publication Critical patent/DK210788A/da
Application granted granted Critical
Publication of DK175519B1 publication Critical patent/DK175519B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8132—Plasminogen activator inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK198802107A 1986-08-19 1988-04-18 Diagnostisk bestemmelse af inhibitor af vævs-type- og urokinasetype-plasminogen-aktivatorer og gen kodende for inhibitoren DK175519B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/897,990 US4952512A (en) 1984-06-22 1986-08-19 Gene encoding an inhibitor of tissue-type and urokinase-type plasminogen activators
US89799086 1986-08-19
PCT/US1987/002053 WO1988001273A1 (en) 1986-08-19 1987-08-19 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor
US8702053 1987-08-19

Publications (3)

Publication Number Publication Date
DK210788D0 DK210788D0 (da) 1988-04-18
DK210788A true DK210788A (da) 1988-06-20
DK175519B1 DK175519B1 (da) 2004-11-22

Family

ID=25408764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802107A DK175519B1 (da) 1986-08-19 1988-04-18 Diagnostisk bestemmelse af inhibitor af vævs-type- og urokinasetype-plasminogen-aktivatorer og gen kodende for inhibitoren

Country Status (10)

Country Link
US (1) US4952512A (da)
EP (1) EP0277212B1 (da)
JP (2) JP2619452B2 (da)
KR (1) KR960005735B1 (da)
AT (1) ATE120757T1 (da)
AU (1) AU611095B2 (da)
DE (1) DE3751224T2 (da)
DK (1) DK175519B1 (da)
NO (1) NO302477B1 (da)
WO (1) WO1988001273A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422090A (en) * 1984-08-13 1995-06-06 Biotechnology Australia, Pty., Ltd. Human PAI-2
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US6271352B1 (en) 1985-07-12 2001-08-07 Fonden Til Fremme Af Eksperimentel Cancerforskning PAI-1 determination and use thereof
US5648254A (en) * 1988-01-15 1997-07-15 Zymogenetics, Inc. Co-expression in eukaryotic cells
SE8802939D0 (sv) * 1988-08-19 1988-08-19 Kabigen Ab A method for the production and isolation of a fusion protein in eukaryotic cells
WO1990013648A1 (en) * 1989-05-11 1990-11-15 E.I. Du Pont De Nemours And Company HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI)
WO1991002057A1 (en) * 1989-08-09 1991-02-21 Delta Biotechnology Limited Polypeptide production in fungi
US5260419A (en) * 1991-03-20 1993-11-09 The Dupont Merck Pharmaceutical Company Purification of active and inactive/latent forms of plasminogen activator inhibitor-1
US6869925B1 (en) 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US5474766A (en) * 1992-12-18 1995-12-12 Washington University Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
US5550213A (en) * 1993-12-27 1996-08-27 Rutgers, The State University Of New Jersey Inhibitors of urokinase plasminogen activator
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
DE29724847U1 (de) * 1996-06-26 2004-09-30 Osram Opto Semiconductors Gmbh Lichtabstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
US6600908B1 (en) 1999-02-04 2003-07-29 Hark C. Chan Method and system for broadcasting and receiving audio information and associated audio indexes
DE602006003651D1 (de) * 2006-08-03 2008-12-24 Cellzome Ag Verfahren zur Identifizierung von Molekülen die mit PI3K interagieren und Verfahren zur Reinigung von PI3K
US20140093556A1 (en) 2011-01-28 2014-04-03 Sanofi Pasteur Sa Immunological Compositions Against HIV

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235960A (en) * 1977-07-29 1980-11-25 The Medical College Of Wisconsin, Inc. Competitive enzyme-linked immunoassay
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
DK319685A (da) * 1985-07-12 1987-01-13 Fonden Til Fremme Af Eksperime Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
NL8602307A (nl) * 1986-09-12 1988-04-05 Stichting Centraal Lab Recombinant dna molekuul; werkwijze voor het bereiden van humane endotheliale plasminogeen activator remmer (pai) of een mutant daarvan; farmaceutisch preparaat; getransformeerde gastheercellen.
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)

Also Published As

Publication number Publication date
US4952512A (en) 1990-08-28
NO302477B1 (no) 1998-03-09
NO881670D0 (no) 1988-04-18
ATE120757T1 (de) 1995-04-15
AU611095B2 (en) 1991-06-06
DE3751224T2 (de) 1995-11-09
DK210788D0 (da) 1988-04-18
DK175519B1 (da) 2004-11-22
JPH09131192A (ja) 1997-05-20
EP0277212A4 (en) 1991-04-10
DE3751224D1 (de) 1995-05-11
JP2685742B2 (ja) 1997-12-03
EP0277212B1 (en) 1995-04-05
JPH01500640A (ja) 1989-03-09
NO881670L (no) 1988-06-17
KR960005735B1 (ko) 1996-05-01
WO1988001273A1 (en) 1988-02-25
EP0277212A1 (en) 1988-08-10
AU7851487A (en) 1988-03-08
JP2619452B2 (ja) 1997-06-11
KR880701728A (ko) 1988-11-04

Similar Documents

Publication Publication Date Title
DK210788A (da) Diagnostisk bestemmelse af inhibitor af vaevs-type-plasminogen-aktivatorer og gen kodende for inhibitoren
DK426386A (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
MY102472A (en) Preparation of funtional human urokinase proteins.
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
NO970603D0 (no) Fremgangsmåte for rensing av et plasminogenaktiverende protein fra vampyrflaggermus
SE8801701D0 (sv) Production technology based on enzymic method
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
ES8607262A1 (es) Esteres de aminoacidos y de peptidos cromogenos
NO982715D0 (no) Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse
DK465986D0 (da) Fremgangsmaade til foraegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator)
ATE62512T1 (de) Verfahren zur bestimmung von plasminogenaktivatoren (pa).
DE69132889D1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
DE59001537D1 (de) Verwendung von polyurethan-mischungen als klebstoffbindemittel zur verklebung von sbs-blockpolymerisaten.
EP0960117A4 (en) ON FIBROBLASTS GROWTH FACTOR HOMOLOGICAL FACTORS (FHFs) AND METHOD OF APPLICATION
ES2079442T3 (es) Oxidacion enzimatica mejorada de cef c a acido glutaril-7-amino-cefalosporanico.
PT88938A (pt) Processo para a preparacao de uma nova variante do activador de plasminogeneo do tecido humano
ES2123043T3 (es) Metodo para la determinacion de fibrinogeno.
DE59309254D1 (de) Verwendung von Prothrombinfragmenten
ATE361913T1 (de) Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren
JPS642600A (en) Kit for measuring protein c activity
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
ES2084056T3 (es) Procedimiento para la deteccion de activadores de plasminogeno, sus inhibidores o estimuladores.
ATE97442T1 (de) Isolierung, reinigung, charakterisierung, klonierung und sequenzierung von n-alphaacetyltransferase.

Legal Events

Date Code Title Description
PUP Patent expired